1.Gimbel AA, Flores E, Koo A, et al. Development of a biomimetic microfluidic oxygen transfer device. Lab Chip, 2016, 16(17):3227-3234.

2.Aubron C, DePuydt J, Belon F, et al. Predictive factors of bleeding events in adults undergoing extracorporeal membrane oxygenation. Ann Intensive Care, 2016, 6:97.

3.Kara A, Akin S, Dos Reis Miranda D, et al. Microcirculatory assessment of patients under VA-ECMO. Critical Care, 2016, 20:344.

4.Pavlushkov E, Berman M, Valchanov K. Cannulation techniques for extracorporeal life support. Ann Transl Med, 2017, 5(4):70.

5.Cho HJ, Kim DW, Kim GS, et al. Anticoagulation therapy during extracorporeal membrane oxygenator support in pediatric patients. Chonnam Med J, 2017, 53:110-117.

6.Gadepalli SK, Hirschl RB. Extracorporeal life support: updates and controversies. Semin Oediatr Surg, 2015, 24(1):8-11.

7.Reitman AJ, Chapman R, Stein JE, et al. The impact of venoarterial and venovenous extracorporeal membrane oxygenation on cerebral metabolism in the newborn brain. PLoS ONE, 2016, 11(12): e0168578.

8.Broman LM, Frenckner B. Transportation of critically ill patients on extracorporeal membrane oxygenation. Front Pediatr, 2016, 4:63.

9.Kapoor PM. From cardio pulmonary bypass to ECMO, mechanical assist devices, quality control and decrease in 30day mortality in cardiac anesthesia—are we nearer our goal. Ann Card Anaesth, 2015, 18(2):129.

10.Prat NJ, Meyer AD, Langer T, et al. Low-dose heparin anticoagulation during extracorporeal life support for acute respiratory distress syndrome in conscious sheep. Shock, 2015, 44(6):560-568.